Dr. Skelding is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
377 Jersey Avenue
450
Jersey City, NJ 07302Phone+1 201-915-2525Fax+1 201-915-2945
Summary
- Dr. Kimberly Skelding is the Division Chief for Cardiovascular Services, Chief of Cardiology at RWJBarnabas Health in Jersey City, NJ. An interventional cardiologist who specializes in the treatment of valvular and coronary heart disease. Lectures nationally and internationally. Published over 100 articles in her field. A nationally known thought leader, researcher and clinician.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Interventional Cardiology, 2004 - 2005
- Corewell Health East Beaumont (Royal Oak)Fellowship, Cardiovascular Disease, 1999 - 2002
- Geisinger Health System (Danville)Residency, Internal Medicine, 1996 - 1999
- Northwestern University The Feinberg School of MedicineClass of 1996
Certifications & Licensure
- NJ State Medical License 2023 - 2025
- VA State Medical License 2019 - 2024
- WA State Medical License 2020 - 2024
- PA State Medical License 1997 - 2022
- GA State Medical License 2020 - 2021
- AL State Medical License 2017 - 2020
- MI State Medical License 1998 - 2005
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
- Join now to see all
Awards, Honors, & Recognition
- Fellow SCAI
- Fellow American Heart Association
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Join now to see all
Clinical Trials
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
- Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2012 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Breaking Down Barriers to Transcatheter Aortic Valve Replacement.Amit N Vora, Wayne B Batchelor, Konstantinos Dean Boudoulas, Ramesh Daggubati, Sammy Elmariah
Journal of the Society for Cardiovascular Angiography & Interventions. 2024-03-01 - Spontaneous Coronary Artery Dissection (SCAD) from an Interventionalist Perspective.Nichole Brunton, Patricia J M Best, Kimberly A Skelding, Emily E Cendrowski
Current Cardiology Reports. 2024-03-01 - Invited Commentary: Impact of New eGFR Equations on Risk Assessment in Patients Undergoing Transcatheter Aortic Valve Replacement.Kimberly A Skelding, Alexander S Kraev
Cardiovascular Revascularization Medicine. 2023-04-01
Press Mentions
- Dr. Skelding, Dr. Lynch, & Dr. Kamal - Top 3 Physicians for Acute Myocardial Infarction Based on Experience and Patient Volume in Tuscaloosa County, AlabamaJuly 13th, 2022
- Hospitals, Physicians Fight for Women's Equity in Healthcare Research, DeliveryOctober 13th, 2014
- Jersey City Medical Center Performs Innovative Carotid Artery TAVR Procedure — Quicker Recovery, Less RiskMay 14th, 2024
Professional Memberships
- Fellow
- Fellow
- Society for Cardiovascular Angiography and InterventionFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: